2012
DOI: 10.1253/circj.cj-12-0301
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Functional, Morphological and Clinical Parameters on Epicardial Adipose Tissue in Patients With Coronary Artery Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
9
0
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 51 publications
2
9
0
1
Order By: Relevance
“…Doesch et al [32] measured EAT volume in patients with dilated cardiomyopathy using MRI and found that it was associated with HF with reduced EF, but not with a preserved EF as in our study. Other studies are in line with that and show a correlation for EAT and reduced LV-EF [33,34]. We concur that the influence of EAT volume on LVDD in patients with AS might be of minor concern as shown by our preliminary data and that an increase in afterload and other changes associated with AS may play a more important role in causing LVDD and LV hypertrophy.…”
Section: Plos Onesupporting
confidence: 90%
“…Doesch et al [32] measured EAT volume in patients with dilated cardiomyopathy using MRI and found that it was associated with HF with reduced EF, but not with a preserved EF as in our study. Other studies are in line with that and show a correlation for EAT and reduced LV-EF [33,34]. We concur that the influence of EAT volume on LVDD in patients with AS might be of minor concern as shown by our preliminary data and that an increase in afterload and other changes associated with AS may play a more important role in causing LVDD and LV hypertrophy.…”
Section: Plos Onesupporting
confidence: 90%
“…Thickness in EAT is also associated with metabolic syndrome, 25 insulin resistance, 26 endothelial dysfunction, 27 and overt atherosclerotic CAD. 28 The influence of conventional cardiovascular risk factors on EAT thickness is well established; regardless, EAT has additional predictive value over these risk factors in regard to the presence of critical and complex CAD, according to our multivariate regression analysis.…”
Section: Discussionmentioning
confidence: 68%
“…In contrast, adiponectin which has antiatherogenic properties through improvement of endothelial function and anti-inflammatory effect was shown to be under expressed in EAT in patients with CAD (16). In the light of these findings, EAT is associated with metabolic syndrome (17), insulin resistance (17, 18), endothelial dysfunction, subclinical atherosclerosis (19) and overt atherosclerotic CAD (20). …”
Section: Discussionmentioning
confidence: 99%